SRXH

SRx Health Solutions Inc. · AMEX · Healthcare · USD · 10-K for 2025, filed 2025-12-05

Figures on this page computed 2026-11-08 13:00 UTC

Last close

0.89USD

Market data, 2026-11-04

Except where said otherwise: 10-K for 2024, filed 2025-03-31

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2024
Accession
0001641172-25-001558
Reported in
USD
- computed
- 10-K for 2024, filed 2025-03-31
The filing itself
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2024
Accession
0001641172-25-001558
Reported in
USD
- 10-K for 2024, filed 2025-03-31
- 10-K for 2024, filed 2025-03-31
- 10-K for 2024, filed 2025-03-31
- 10-Q for 2024, filed 2026-08-13
- 10-K for 2024, filed 2025-03-31
- 10-Q for 2024, filed 2025-05-15
The filing itself
-0.5%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2024
Accession
0001641172-25-001558
Reported in
USD
- 10-K for 2024, filed 2025-03-31
- 10-K for 2024, filed 2025-03-31
The filing itself
-12.6%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2024
Accession
0001641172-25-001558
Reported in
USD
- 10-K for 2024, filed 2025-03-31
- 10-K for 2024, filed 2025-03-31
The filing itself
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2024
Accession
0001641172-25-001558
Reported in
USD
- 10-K for 2024, filed 2025-03-31
- 10-Q for 2024, filed 2026-08-13
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Safety is the furthest below its sector's middle: 0.29 against 0.52 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

All from 100

lens 2 of 9

Sales

13,612,500

2016-08-31 to 2025-09-30100 at the start13,612,500

Sales: 100.00 on 2016-08-31 to 13612500.00 on 2025-09-30, up 13612400%.

Shares in issue

30.0

2016-08-31 to 2025-09-30100 at the start30.0

Shares in issue: 100.00 on 2016-08-31 to 29.95 on 2025-09-30, down 70%.

Profit, where the first year is 100: n/aNot enough filed years carry this line for it to be drawn. No line is drawn flat in its place.

Sales is at 13612500, Shares in issue is at 30, against 100 in 2016.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2025-12-05

Sales, where the first year is 10013,612,500
Source
filed
Statement
income
Fiscal year
2025
Accession
0001493152-25-026452
Reported in
USD
The filing itself
Profit, where the first year is 100n/a
Not held.
Source
filed
Statement
income
Fiscal year
2025
Accession
0001493152-25-026452
Reported in
USD
The filing itself
Shares in issue, where the first year is 10030
Source
filed
Statement
income
Fiscal year
2025
Accession
0001493152-25-026452
Reported in
USD
The filing itself